Bright Minds Biosciences Inc. - common stock (DRUG)

Bright Minds Biosciences Inc. is a biopharmaceutical company focused on developing innovative therapies to treat various neuropsychiatric disorders

By leveraging advanced science and extensive research, the company aims to create new treatment options that address the underlying mechanisms of these conditions, ultimately improving the quality of life for patients. Their pipeline includes compounds that target unmet medical needs while prioritizing safety and efficacy. Through a combination of clinical trials and cutting-edge technology, Bright Minds seeks to advance the field of mental health treatment and contribute to the growing landscape of psychedelic-based medicine.